Global Patient-derived Xenograft (PDX) Models Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Mouse Model
1.2.3 Rat Model
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Preclinical Drug development
1.3.3 Biomarker Analysis
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Patient-derived Xenograft (PDX) Models Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Patient-derived Xenograft (PDX) Models Revenue Market Share by Region (2020-2025)
2.4 Global Patient-derived Xenograft (PDX) Models Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Patient-derived Xenograft (PDX) Models Market Size and Prospective (2020-2031)
2.5.2 Europe Patient-derived Xenograft (PDX) Models Market Size and Prospective (2020-2031)
2.5.3 China Patient-derived Xenograft (PDX) Models Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Patient-derived Xenograft (PDX) Models Historic Market Size by Type (2020-2025)
3.2 Global Patient-derived Xenograft (PDX) Models Forecasted Market Size by Type (2026-2031)
3.3 Different Types Patient-derived Xenograft (PDX) Models Representative Players
4 Breakdown Data by Application
4.1 Global Patient-derived Xenograft (PDX) Models Historic Market Size by Application (2020-2025)
4.2 Global Patient-derived Xenograft (PDX) Models Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Patient-derived Xenograft (PDX) Models Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Patient-derived Xenograft (PDX) Models Players by Revenue (2020-2025)
5.1.2 Global Patient-derived Xenograft (PDX) Models Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Patient-derived Xenograft (PDX) Models Revenue
5.4 Global Patient-derived Xenograft (PDX) Models Market Concentration Analysis
5.4.1 Global Patient-derived Xenograft (PDX) Models Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Patient-derived Xenograft (PDX) Models Revenue in 2024
5.5 Global Key Players of Patient-derived Xenograft (PDX) Models Head office and Area Served
5.6 Global Key Players of Patient-derived Xenograft (PDX) Models, Product and Application
5.7 Global Key Players of Patient-derived Xenograft (PDX) Models, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Patient-derived Xenograft (PDX) Models Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Patient-derived Xenograft (PDX) Models Market Size by Type (2020-2025)
6.1.2.2 North America Patient-derived Xenograft (PDX) Models Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Patient-derived Xenograft (PDX) Models Market Size by Application (2020-2025)
6.1.3.2 North America Patient-derived Xenograft (PDX) Models Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Patient-derived Xenograft (PDX) Models Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Patient-derived Xenograft (PDX) Models Market Size by Type (2020-2025)
6.2.2.2 Europe Patient-derived Xenograft (PDX) Models Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Patient-derived Xenograft (PDX) Models Market Size by Application (2020-2025)
6.2.3.2 Europe Patient-derived Xenograft (PDX) Models Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Patient-derived Xenograft (PDX) Models Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Patient-derived Xenograft (PDX) Models Market Size by Type (2020-2025)
6.3.2.2 China Patient-derived Xenograft (PDX) Models Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Patient-derived Xenograft (PDX) Models Market Size by Application (2020-2025)
6.3.3.2 China Patient-derived Xenograft (PDX) Models Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
7 Key Players Profiles
7.1 Crown Bioscience
7.1.1 Crown Bioscience Company Details
7.1.2 Crown Bioscience Business Overview
7.1.3 Crown Bioscience Patient-derived Xenograft (PDX) Models Introduction
7.1.4 Crown Bioscience Revenue in Patient-derived Xenograft (PDX) Models Business (2020-2025)
7.1.5 Crown Bioscience Recent Development
7.2 Champions Oncology
7.2.1 Champions Oncology Company Details
7.2.2 Champions Oncology Business Overview
7.2.3 Champions Oncology Patient-derived Xenograft (PDX) Models Introduction
7.2.4 Champions Oncology Revenue in Patient-derived Xenograft (PDX) Models Business (2020-2025)
7.2.5 Champions Oncology Recent Development
7.3 Wuxi Apptec
7.3.1 Wuxi Apptec Company Details
7.3.2 Wuxi Apptec Business Overview
7.3.3 Wuxi Apptec Patient-derived Xenograft (PDX) Models Introduction
7.3.4 Wuxi Apptec Revenue in Patient-derived Xenograft (PDX) Models Business (2020-2025)
7.3.5 Wuxi Apptec Recent Development
7.4 The Jackson Laboratory
7.4.1 The Jackson Laboratory Company Details
7.4.2 The Jackson Laboratory Business Overview
7.4.3 The Jackson Laboratory Patient-derived Xenograft (PDX) Models Introduction
7.4.4 The Jackson Laboratory Revenue in Patient-derived Xenograft (PDX) Models Business (2020-2025)
7.4.5 The Jackson Laboratory Recent Development
7.5 EPO Berlin-Buch
7.5.1 EPO Berlin-Buch Company Details
7.5.2 EPO Berlin-Buch Business Overview
7.5.3 EPO Berlin-Buch Patient-derived Xenograft (PDX) Models Introduction
7.5.4 EPO Berlin-Buch Revenue in Patient-derived Xenograft (PDX) Models Business (2020-2025)
7.5.5 EPO Berlin-Buch Recent Development
7.6 Oncodesign
7.6.1 Oncodesign Company Details
7.6.2 Oncodesign Business Overview
7.6.3 Oncodesign Patient-derived Xenograft (PDX) Models Introduction
7.6.4 Oncodesign Revenue in Patient-derived Xenograft (PDX) Models Business (2020-2025)
7.6.5 Oncodesign Recent Development
7.7 Xentech
7.7.1 Xentech Company Details
7.7.2 Xentech Business Overview
7.7.3 Xentech Patient-derived Xenograft (PDX) Models Introduction
7.7.4 Xentech Revenue in Patient-derived Xenograft (PDX) Models Business (2020-2025)
7.7.5 Xentech Recent Development
7.8 Envigo
7.8.1 Envigo Company Details
7.8.2 Envigo Business Overview
7.8.3 Envigo Patient-derived Xenograft (PDX) Models Introduction
7.8.4 Envigo Revenue in Patient-derived Xenograft (PDX) Models Business (2020-2025)
7.8.5 Envigo Recent Development
7.9 Charles River Laboratories
7.9.1 Charles River Laboratories Company Details
7.9.2 Charles River Laboratories Business Overview
7.9.3 Charles River Laboratories Patient-derived Xenograft (PDX) Models Introduction
7.9.4 Charles River Laboratories Revenue in Patient-derived Xenograft (PDX) Models Business (2020-2025)
7.9.5 Charles River Laboratories Recent Development
7.10 Pharmatest Services
7.10.1 Pharmatest Services Company Details
7.10.2 Pharmatest Services Business Overview
7.10.3 Pharmatest Services Patient-derived Xenograft (PDX) Models Introduction
7.10.4 Pharmatest Services Revenue in Patient-derived Xenograft (PDX) Models Business (2020-2025)
7.10.5 Pharmatest Services Recent Development
7.11 Urosphere
7.11.1 Urosphere Company Details
7.11.2 Urosphere Business Overview
7.11.3 Urosphere Patient-derived Xenograft (PDX) Models Introduction
7.11.4 Urosphere Revenue in Patient-derived Xenograft (PDX) Models Business (2020-2025)
7.11.5 Urosphere Recent Development
7.12 MEDICILON
7.12.1 MEDICILON Company Details
7.12.2 MEDICILON Business Overview
7.12.3 MEDICILON Patient-derived Xenograft (PDX) Models Introduction
7.12.4 MEDICILON Revenue in Patient-derived Xenograft (PDX) Models Business (2020-2025)
7.12.5 MEDICILON Recent Development
7.13 Horizon Discovery
7.13.1 Horizon Discovery Company Details
7.13.2 Horizon Discovery Business Overview
7.13.3 Horizon Discovery Patient-derived Xenograft (PDX) Models Introduction
7.13.4 Horizon Discovery Revenue in Patient-derived Xenograft (PDX) Models Business (2020-2025)
7.13.5 Horizon Discovery Recent Development
7.14 Shanghai Model Organisms Center
7.14.1 Shanghai Model Organisms Center Company Details
7.14.2 Shanghai Model Organisms Center Business Overview
7.14.3 Shanghai Model Organisms Center Patient-derived Xenograft (PDX) Models Introduction
7.14.4 Shanghai Model Organisms Center Revenue in Patient-derived Xenograft (PDX) Models Business (2020-2025)
7.14.5 Shanghai Model Organisms Center Recent Development
7.15 GemPharmatech
7.15.1 GemPharmatech Company Details
7.15.2 GemPharmatech Business Overview
7.15.3 GemPharmatech Patient-derived Xenograft (PDX) Models Introduction
7.15.4 GemPharmatech Revenue in Patient-derived Xenograft (PDX) Models Business (2020-2025)
7.15.5 GemPharmatech Recent Development
7.16 LIDE Biotech
7.16.1 LIDE Biotech Company Details
7.16.2 LIDE Biotech Business Overview
7.16.3 LIDE Biotech Patient-derived Xenograft (PDX) Models Introduction
7.16.4 LIDE Biotech Revenue in Patient-derived Xenograft (PDX) Models Business (2020-2025)
7.16.5 LIDE Biotech Recent Development
8 Patient-derived Xenograft (PDX) Models Market Dynamics
8.1 Patient-derived Xenograft (PDX) Models Industry Trends
8.2 Patient-derived Xenograft (PDX) Models Market Drivers
8.3 Patient-derived Xenograft (PDX) Models Market Challenges
8.4 Patient-derived Xenograft (PDX) Models Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer

List of Tables
Table 1. Global Patient-derived Xenograft (PDX) Models Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Patient-derived Xenograft (PDX) Models Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Patient-derived Xenograft (PDX) Models Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Patient-derived Xenograft (PDX) Models Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Patient-derived Xenograft (PDX) Models Revenue Share by Region (2020-2025)
Table 6. Global Patient-derived Xenograft (PDX) Models Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Patient-derived Xenograft (PDX) Models Revenue Share Forecast by Region (2026-2031)
Table 8. Global Patient-derived Xenograft (PDX) Models Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Patient-derived Xenograft (PDX) Models Revenue Market Share by Type (2020-2025)
Table 10. Global Patient-derived Xenograft (PDX) Models Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Patient-derived Xenograft (PDX) Models Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Patient-derived Xenograft (PDX) Models Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Patient-derived Xenograft (PDX) Models Revenue Market Share by Application (2020-2025)
Table 15. Global Patient-derived Xenograft (PDX) Models Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Patient-derived Xenograft (PDX) Models Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Patient-derived Xenograft (PDX) Models Application
Table 18. Global Patient-derived Xenograft (PDX) Models Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Patient-derived Xenograft (PDX) Models Market Share by Players (2020-2025)
Table 20. Global Top Patient-derived Xenograft (PDX) Models Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Patient-derived Xenograft (PDX) Models as of 2024)
Table 21. Ranking of Global Top Patient-derived Xenograft (PDX) Models Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Patient-derived Xenograft (PDX) Models Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Patient-derived Xenograft (PDX) Models, Headquarters and Area Served
Table 24. Global Key Players of Patient-derived Xenograft (PDX) Models, Product and Application
Table 25. Global Key Players of Patient-derived Xenograft (PDX) Models, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Patient-derived Xenograft (PDX) Models Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Patient-derived Xenograft (PDX) Models Revenue Market Share by Company (2020-2025)
Table 29. North America Patient-derived Xenograft (PDX) Models Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Patient-derived Xenograft (PDX) Models Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Patient-derived Xenograft (PDX) Models Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Patient-derived Xenograft (PDX) Models Revenue Market Share by Company (2020-2025)
Table 33. Europe Patient-derived Xenograft (PDX) Models Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Patient-derived Xenograft (PDX) Models Market Size by Application (2020-2025) & (US$ Million)
Table 35. China Patient-derived Xenograft (PDX) Models Revenue by Company (2020-2025) & (US$ Million)
Table 36. China Patient-derived Xenograft (PDX) Models Revenue Market Share by Company (2020-2025)
Table 37. China Patient-derived Xenograft (PDX) Models Market Size by Type (2020-2025) & (US$ Million)
Table 38. China Patient-derived Xenograft (PDX) Models Market Size by Application (2020-2025) & (US$ Million)
Table 39. Crown Bioscience Company Details
Table 40. Crown Bioscience Business Overview
Table 41. Crown Bioscience Patient-derived Xenograft (PDX) Models Product
Table 42. Crown Bioscience Revenue in Patient-derived Xenograft (PDX) Models Business (2020-2025) & (US$ Million)
Table 43. Crown Bioscience Recent Development
Table 44. Champions Oncology Company Details
Table 45. Champions Oncology Business Overview
Table 46. Champions Oncology Patient-derived Xenograft (PDX) Models Product
Table 47. Champions Oncology Revenue in Patient-derived Xenograft (PDX) Models Business (2020-2025) & (US$ Million)
Table 48. Champions Oncology Recent Development
Table 49. Wuxi Apptec Company Details
Table 50. Wuxi Apptec Business Overview
Table 51. Wuxi Apptec Patient-derived Xenograft (PDX) Models Product
Table 52. Wuxi Apptec Revenue in Patient-derived Xenograft (PDX) Models Business (2020-2025) & (US$ Million)
Table 53. Wuxi Apptec Recent Development
Table 54. The Jackson Laboratory Company Details
Table 55. The Jackson Laboratory Business Overview
Table 56. The Jackson Laboratory Patient-derived Xenograft (PDX) Models Product
Table 57. The Jackson Laboratory Revenue in Patient-derived Xenograft (PDX) Models Business (2020-2025) & (US$ Million)
Table 58. The Jackson Laboratory Recent Development
Table 59. EPO Berlin-Buch Company Details
Table 60. EPO Berlin-Buch Business Overview
Table 61. EPO Berlin-Buch Patient-derived Xenograft (PDX) Models Product
Table 62. EPO Berlin-Buch Revenue in Patient-derived Xenograft (PDX) Models Business (2020-2025) & (US$ Million)
Table 63. EPO Berlin-Buch Recent Development
Table 64. Oncodesign Company Details
Table 65. Oncodesign Business Overview
Table 66. Oncodesign Patient-derived Xenograft (PDX) Models Product
Table 67. Oncodesign Revenue in Patient-derived Xenograft (PDX) Models Business (2020-2025) & (US$ Million)
Table 68. Oncodesign Recent Development
Table 69. Xentech Company Details
Table 70. Xentech Business Overview
Table 71. Xentech Patient-derived Xenograft (PDX) Models Product
Table 72. Xentech Revenue in Patient-derived Xenograft (PDX) Models Business (2020-2025) & (US$ Million)
Table 73. Xentech Recent Development
Table 74. Envigo Company Details
Table 75. Envigo Business Overview
Table 76. Envigo Patient-derived Xenograft (PDX) Models Product
Table 77. Envigo Revenue in Patient-derived Xenograft (PDX) Models Business (2020-2025) & (US$ Million)
Table 78. Envigo Recent Development
Table 79. Charles River Laboratories Company Details
Table 80. Charles River Laboratories Business Overview
Table 81. Charles River Laboratories Patient-derived Xenograft (PDX) Models Product
Table 82. Charles River Laboratories Revenue in Patient-derived Xenograft (PDX) Models Business (2020-2025) & (US$ Million)
Table 83. Charles River Laboratories Recent Development
Table 84. Pharmatest Services Company Details
Table 85. Pharmatest Services Business Overview
Table 86. Pharmatest Services Patient-derived Xenograft (PDX) Models Product
Table 87. Pharmatest Services Revenue in Patient-derived Xenograft (PDX) Models Business (2020-2025) & (US$ Million)
Table 88. Pharmatest Services Recent Development
Table 89. Urosphere Company Details
Table 90. Urosphere Business Overview
Table 91. Urosphere Patient-derived Xenograft (PDX) Models Product
Table 92. Urosphere Revenue in Patient-derived Xenograft (PDX) Models Business (2020-2025) & (US$ Million)
Table 93. Urosphere Recent Development
Table 94. MEDICILON Company Details
Table 95. MEDICILON Business Overview
Table 96. MEDICILON Patient-derived Xenograft (PDX) Models Product
Table 97. MEDICILON Revenue in Patient-derived Xenograft (PDX) Models Business (2020-2025) & (US$ Million)
Table 98. MEDICILON Recent Development
Table 99. Horizon Discovery Company Details
Table 100. Horizon Discovery Business Overview
Table 101. Horizon Discovery Patient-derived Xenograft (PDX) Models Product
Table 102. Horizon Discovery Revenue in Patient-derived Xenograft (PDX) Models Business (2020-2025) & (US$ Million)
Table 103. Horizon Discovery Recent Development
Table 104. Shanghai Model Organisms Center Company Details
Table 105. Shanghai Model Organisms Center Business Overview
Table 106. Shanghai Model Organisms Center Patient-derived Xenograft (PDX) Models Product
Table 107. Shanghai Model Organisms Center Revenue in Patient-derived Xenograft (PDX) Models Business (2020-2025) & (US$ Million)
Table 108. Shanghai Model Organisms Center Recent Development
Table 109. GemPharmatech Company Details
Table 110. GemPharmatech Business Overview
Table 111. GemPharmatech Patient-derived Xenograft (PDX) Models Product
Table 112. GemPharmatech Revenue in Patient-derived Xenograft (PDX) Models Business (2020-2025) & (US$ Million)
Table 113. GemPharmatech Recent Development
Table 114. LIDE Biotech Company Details
Table 115. LIDE Biotech Business Overview
Table 116. LIDE Biotech Patient-derived Xenograft (PDX) Models Product
Table 117. LIDE Biotech Revenue in Patient-derived Xenograft (PDX) Models Business (2020-2025) & (US$ Million)
Table 118. LIDE Biotech Recent Development
Table 119. Patient-derived Xenograft (PDX) Models Market Trends
Table 120. Patient-derived Xenograft (PDX) Models Market Drivers
Table 121. Patient-derived Xenograft (PDX) Models Market Challenges
Table 122. Patient-derived Xenograft (PDX) Models Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources


List of Figures
Figure 1. Patient-derived Xenograft (PDX) Models Product Picture
Figure 2. Global Patient-derived Xenograft (PDX) Models Market Share by Type: 2024 VS 2031
Figure 3. Mouse Model Features
Figure 4. Rat Model Features
Figure 5. Global Patient-derived Xenograft (PDX) Models Market Share by Application: 2024 VS 2031
Figure 6. Preclinical Drug development
Figure 7. Biomarker Analysis
Figure 8. Patient-derived Xenograft (PDX) Models Report Years Considered
Figure 9. Global Patient-derived Xenograft (PDX) Models Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 10. Global Patient-derived Xenograft (PDX) Models Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Patient-derived Xenograft (PDX) Models Revenue Market Share by Region: 2020 VS 2024
Figure 12. North America Patient-derived Xenograft (PDX) Models Revenue (US$ Million) Growth Rate (2020-2031)
Figure 13. Europe Patient-derived Xenograft (PDX) Models Revenue (US$ Million) Growth Rate (2020-2031)
Figure 14. China Patient-derived Xenograft (PDX) Models Revenue (US$ Million) Growth Rate (2020-2031)
Figure 15. Global Patient-derived Xenograft (PDX) Models Market Share by Players in 2024
Figure 16. Global Top Patient-derived Xenograft (PDX) Models Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Patient-derived Xenograft (PDX) Models as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Patient-derived Xenograft (PDX) Models Revenue in 2024
Figure 18. North America Patient-derived Xenograft (PDX) Models Market Share by Type (2020-2025)
Figure 19. North America Patient-derived Xenograft (PDX) Models Market Share by Application (2020-2025)
Figure 20. Europe Patient-derived Xenograft (PDX) Models Market Share by Type (2020-2025)
Figure 21. Europe Patient-derived Xenograft (PDX) Models Market Share by Application (2020-2025)
Figure 22. China Patient-derived Xenograft (PDX) Models Market Share by Type (2020-2025)
Figure 23. China Patient-derived Xenograft (PDX) Models Market Share by Application (2020-2025)
Figure 24. Crown Bioscience Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2020-2025)
Figure 25. Champions Oncology Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2020-2025)
Figure 26. Wuxi Apptec Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2020-2025)
Figure 27. The Jackson Laboratory Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2020-2025)
Figure 28. EPO Berlin-Buch Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2020-2025)
Figure 29. Oncodesign Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2020-2025)
Figure 30. Xentech Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2020-2025)
Figure 31. Envigo Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2020-2025)
Figure 32. Charles River Laboratories Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2020-2025)
Figure 33. Pharmatest Services Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2020-2025)
Figure 34. Urosphere Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2020-2025)
Figure 35. MEDICILON Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2020-2025)
Figure 36. Horizon Discovery Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2020-2025)
Figure 37. Shanghai Model Organisms Center Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2020-2025)
Figure 38. GemPharmatech Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2020-2025)
Figure 39. LIDE Biotech Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2020-2025)
Figure 40. Bottom-up and Top-down Approaches for This Report
Figure 41. Data Triangulation
Figure 42. Key Executives Interviewed

Your Name

Your E-mail

Your message

Submit